Dimitrios Voulgaris

Dimitrios Voulgaris is a scientist at Procella Therapeutics AB since June 2022, with a robust research background that includes positions as a research engineer and doctoral researcher at KTH Royal Institute of Technology from November 2016 to May 2022. Previous experience includes a master thesis project at AstraZeneca, which focused on evaluating small molecules for neural differentiation of induced pluripotent stem cells (iPSCs), yielding significant findings on efficiency in neuralization. Additionally, Dimitrios completed a bachelor thesis at the University of Crete and an internship at the Foundation for Research and Technology - Hellas (FORTH). Academic qualifications include a Doctor of Philosophy in in vitro neural systems from KTH Royal Institute of Technology, a Master of Science in Biotechnology from Chalmers University of Technology, and a Bachelor of Science in Materials Science and Technology from the University of Crete.